Mobile Gamma Cameras Market Expected to Reach USD 543 Million by 2034 with Steady Growth - SRI

London, UK - August 2026 | Strategic Revenue Insights Inc. - Imaging is following patients out of the radiology suite. A growing preference for bedside and home-based care is pushing hospitals toward portable diagnostic tools that don't require moving a patient to a fixed scanner, and mobile gamma cameras are increasingly filling that role in emergency departments, intensive care units, and even home healthcare settings. According to a new report from Strategic Revenue Insights, the global mobile gamma cameras market was valued at USD 350 million in 2025 and is projected to reach USD 543 million by 2034, growing at a CAGR of 5.00% over the forecast period. The report was led by analyst Anirudh Singh, with findings drawn from primary interviews with nuclear medicine specialists, hospital procurement teams, and device manufacturers, supplemented by secondary data across Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa.

Key Takeaways

• The mobile gamma cameras market is valued at USD 350 million in 2025 and is forecast to reach USD 543 million by 2034, a CAGR of 5.00%.
• Portable Gamma Cameras lead the market by product type, while Cadmium Zinc Telluride (CZT) detector technology is the fastest-growing segment due to its superior imaging capabilities.
• The integration of digital technologies and AI is improving image processing and diagnostic accuracy, reducing time to diagnosis.
• North America leads the market due to advanced healthcare infrastructure, while Asia Pacific is expected to witness the highest growth rate.
• Star Equity (Digirad), Dilon Technologies, GE HealthCare, and Siemens Healthineers are among the leading companies.

Full report access: https://www.strategicrevenueinsights.com/industry/mobile-gamma-cameras-market

Portability, Precision, and Aging Populations Are Converging

The rising prevalence of chronic diseases is a central driver of the market, as the World Health Organization has reported an increasing global burden of chronic disease that is fueling demand for diagnostic imaging. A growing geriatric population, more susceptible to conditions requiring imaging, is compounding this demand, pushing healthcare providers toward mobile gamma cameras for their flexibility and precision. Regulatory conditions are also part of this picture: transitional deadlines under the European medical device framework have been staggered by risk class, giving higher-risk implantable devices until the end of 2027 and medium and lower-risk devices until the end of 2028 to complete conformity assessment, while the withdrawal of the original sell-off restriction lets compliant devices already on the market remain available without a fixed cut-off.

Technology is reshaping what these devices can do. The shift toward Cadmium Zinc Telluride and semiconductor-based detector technologies is improving image quality and processing speed, which matters most in complex diagnostic cases, and manufacturers are responding by integrating AI-driven image processing to cut diagnosis time and improve accuracy. This technical progress is aligning with a broader move toward value-based healthcare, where mobile gamma cameras offer high-quality imaging at lower cost than fixed imaging modalities, a proposition that is particularly attractive in cost-constrained and emerging markets.

Notified body capacity constraints have continued to shape certification queues through 2025 and 2026, prompting manufacturers to rationalize product portfolios rather than renew every legacy device, even as safety and clinical evidence expectations, including post-market clinical follow-up obligations, remain fully in force.

Market Segmentation

By product type, Portable Gamma Cameras lead the market, valued for their flexibility and ease of use in emergency and intensive care settings. Compact Mobile SPECT Systems and Handheld Gamma Probes are gaining traction for specialized applications such as sentinel lymph node mapping and intraoperative imaging, supported by growing demand for personalized, detailed diagnostic imaging.

By detector technology, Cadmium Zinc Telluride is the fastest-growing segment, prized for superior imaging capability and faster processing. Scintillation detectors (NaI, CsI) remain a significant, reliable, and cost-effective segment widely used in cardiac imaging and bone scintigraphy, while semiconductor-based detectors are gaining attention for their sensitivity and image quality.

By application, Sentinel Lymph Node Mapping is a major segment, driven by rising cancer prevalence and the need for accurate staging and treatment planning. Cardiac Imaging and Thyroid & Parathyroid Imaging are also significant applications benefiting from non-invasive, accurate diagnosis, while Intraoperative Imaging and Pediatric Nuclear Medicine are emerging application areas.

By end use, Hospitals are the largest segment, driven by rising demand for advanced diagnostic imaging. Nuclear Medicine Departments and Ambulatory Surgical Centers are also significant end users valuing the portability of these devices, while Research Institutes and Veterinary Practices are emerging as newer end-use segments.

Regional Outlook

North America dominates the mobile gamma cameras market due to advanced healthcare infrastructure. Asia Pacific is expected to witness the highest growth rate. The report also covers Latin America, Europe, and the Middle East & Africa as part of its regional scope, rounding out a global view of demand for mobile gamma cameras.

Competitive Landscape

Star Equity (Digirad) is known for innovative, portable, user-friendly mobile gamma camera solutions designed for varied healthcare settings. Dilon Technologies offers advanced imaging solutions widely used in hospitals and diagnostic centers, built on a reputation for quality and innovation. GE HealthCare and Siemens Healthineers are leading players with cutting-edge technologies, comprehensive product portfolios, and strong global reach, maintained through continued R&D investment and strategic partnerships. Mediso, CardiArc, Crystal Photonics, SurgicEye, and Mirion (Capintec) round out the competitive landscape, each offering specialized imaging solutions aimed at enhancing diagnostic accuracy and efficiency for specific customer needs.

Market Restraints

The high cost of mobile gamma cameras remains a barrier to adoption, particularly in cost-sensitive markets where the initial investment can limit accessibility for smaller healthcare facilities. Stringent regulatory requirements for medical devices can also delay product approvals and increase development costs, adding further pressure on manufacturers' profitability.

Related Reports

https://www.strategicrevenueinsights.com/industry/pharmaceutical-supply-chain-security-market

https://www.strategicrevenueinsights.com/industry/repurposed-human-immunosuppressants-market

https://www.strategicrevenueinsights.com/industry/revenue-cycle-denials-intelligence-market

https://www.strategicrevenueinsights.com/industry/single-use-bioprocessing-market

https://www.strategicrevenueinsights.com/industry/solid-oral-dosage-protac-degrader-formulations-market

Frequently Asked Questions

What is the mobile gamma cameras market size and growth forecast?

The market was valued at USD 350 million in 2025 and is projected to reach USD 543 million by 2034, growing at a CAGR of 5.00%.

What is driving growth in the mobile gamma cameras market?

Growth is driven by the increasing prevalence of chronic diseases and rising demand for non-invasive diagnostic imaging solutions.

Which region leads the mobile gamma cameras market?

North America dominates the market due to advanced healthcare infrastructure, while Asia Pacific is expected to see the highest growth rate.

Who are the leading companies in the mobile gamma cameras market?

Star Equity (Digirad), Dilon Technologies, GE HealthCare, and Siemens Healthineers are among the leading companies in the mobile gamma cameras market.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases